EPCAM and non-small cell lung carcinoma: Median EpCAM+ taMPs values were significantly elevated (one-way ANOVA) in patients with CRC (n = 52), NSCLC (n = 40), PaCa (n = 11) by an average of 2.3 fold irrespective of the tumour entity and size (Figure 1A and Table 1).